General Influenza Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064650
  • May 2021
  • Medical Devices
  • 137 Pages
The General Influenza Diagnostics market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights General Influenza Diagnostics market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Endress+Hauser (Analytik Jena AG), Becton, Dickinson and Company, Biocartis, bioMérieux Inc, Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd, GenMark Diagnostics, Inc., Luminex Corporation, Meridian Bioscience, Inc, uidel Corporation, hermo Fisher Scientific Inc., ologic, oris Bioconcept\', enome Diagnostic
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for General Influenza Diagnostics market along with their effects over the forecast period. Similarly, according to the region General Influenza Diagnostics market research report includes the study of opportunities available in the market situation.

The General Influenza Diagnostics market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global General Influenza Diagnostics Market:
The General Influenza Diagnostics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Endress+Hauser (Analytik Jena AG), Becton, Dickinson and Company, Biocartis, bioMérieux Inc, Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd, GenMark Diagnostics, Inc., Luminex Corporation, Meridian Bioscience, Inc, uidel Corporation, hermo Fisher Scientific Inc., ologic, oris Bioconcept\', enome Diagnostic

General Influenza Diagnostics Market Segmentation Analysis:
By Test Type
Molecular Diagnostic Tests
Traditional Diagnostic Tests
Flu Type
Type A Flu
Type B Flu
Type C Flu.
End-User
Hospitals
Diagnostic Laboratories
Research and Academic Institutes
Contract Research Organizations
CROs

Global General Influenza Diagnostics Market Segmentation by Regions:
In regional analysis, General Influenza Diagnostics market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global General Influenza Diagnostics market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for General Influenza Diagnostics Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for General Influenza Diagnostics Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for General Influenza Diagnostics Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for General Influenza Diagnostics Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for General Influenza Diagnostics Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the General Influenza Diagnostics market, according to the key region.
  • To study the General Influenza Diagnostics market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of General Influenza Diagnostics market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global General Influenza Diagnostics research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the General Influenza Diagnostics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the General Influenza Diagnostics market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the General Influenza Diagnostics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the General Influenza Diagnostics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the General Influenza Diagnostics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Endress+Hauser (Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Inc
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc
  • uidel Corporation
  • hermo Fisher Scientific Inc.
  • ologic
  • oris Bioconcept'
  • enome Diagnostic
  • Molecular Diagnostic Tests
  • Traditional Diagnostic Tests
  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Contract Research Organizations
  • CROs

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global General Influenza Diagnostics Market Snapshot
          2.1.1. Global General Influenza Diagnostics Market By Test Type,2019
               2.1.1.1.Molecular Diagnostic Tests
               2.1.1.2.Traditional Diagnostic Tests
          2.1.2. Global General Influenza Diagnostics Market By End-User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Diagnostic Laboratories
               2.1.2.3.Research and Academic Institutes
               2.1.2.4.Contract Research Organizations
               2.1.2.5.CROs
          2.1.3. Global General Influenza Diagnostics Market By End-use,2019
          2.1.4. Global General Influenza Diagnostics Market By Geography,2019

3. Global General Influenza Diagnostics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Test Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Test Type, 2020
     4.2. Global General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028

5. Global General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-User, 2020
     5.2. Global General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028

6. Global General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028

7. Global General Influenza Diagnostics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America General Influenza Diagnostics Market Analysis, 2018 – 2028 
          7.2.1. North America General Influenza Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.2.3. North America General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028
          7.2.4. North America General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe General Influenza Diagnostics Market Analysis, 2018 – 2028 
          7.3.1.  Europe General Influenza Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.3.3. Europe General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028
          7.3.4. Europe General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific General Influenza Diagnostics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific General Influenza Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.4.3. Asia Pacific General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028
          7.4.4. Asia Pacific General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America General Influenza Diagnostics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America General Influenza Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.5.3. Latin America General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028
          7.5.4. Latin America General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) General Influenza Diagnostics Market Analysis, 2018 – 2028 
          7.6.1.  MEA General Influenza Diagnostics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA General Influenza Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.6.3. MEA General Influenza Diagnostics Market Size (US$), By End-User, 2018 – 2028
          7.6.4. MEA General Influenza Diagnostics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key General Influenza Diagnostics Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Endress+Hauser (Analytik Jena AG)
                8.4.2.1 Business Description
                8.4.2.2 Endress+Hauser (Analytik Jena AG) Geographic Operations
                8.4.2.3 Endress+Hauser (Analytik Jena AG) Financial Information
                8.4.2.4 Endress+Hauser (Analytik Jena AG) Product Positions/Portfolio
                8.4.2.5 Endress+Hauser (Analytik Jena AG) Key Developments
        8.4.3 Becton, Dickinson and Company
                8.4.3.1 Business Description
                8.4.3.2 Becton, Dickinson and Company Geographic Operations
                8.4.3.3 Becton, Dickinson and Company Financial Information
                8.4.3.4 Becton, Dickinson and Company Product Positions/Portfolio
                8.4.3.5 Becton, Dickinson and Company Key Developments
        8.4.4 Biocartis
                8.4.4.1 Business Description
                8.4.4.2 Biocartis Geographic Operations
                8.4.4.3 Biocartis Financial Information
                8.4.4.4 Biocartis Product Positions/Portfolio
                8.4.4.5 Biocartis Key Developments
        8.4.5 bioMérieux Inc
                8.4.5.1 Business Description
                8.4.5.2 bioMérieux Inc Geographic Operations
                8.4.5.3 bioMérieux Inc Financial Information
                8.4.5.4 bioMérieux Inc Product Positions/Portfolio
                8.4.5.5 bioMérieux Inc Key Developments
        8.4.6 Danaher Corporation (Cepheid)
                8.4.6.1 Business Description
                8.4.6.2 Danaher Corporation (Cepheid) Geographic Operations
                8.4.6.3 Danaher Corporation (Cepheid) Financial Information
                8.4.6.4 Danaher Corporation (Cepheid) Product Positions/Portfolio
                8.4.6.5 Danaher Corporation (Cepheid) Key Developments
        8.4.7 F. Hoffmann-La Roche Ltd
                8.4.7.1 Business Description
                8.4.7.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.7.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.7.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.7.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.8 GenMark Diagnostics, Inc.
                8.4.8.1 Business Description
                8.4.8.2 GenMark Diagnostics, Inc. Geographic Operations
                8.4.8.3 GenMark Diagnostics, Inc. Financial Information
                8.4.8.4 GenMark Diagnostics, Inc. Product Positions/Portfolio
                8.4.8.5 GenMark Diagnostics, Inc. Key Developments
        8.4.9 Luminex Corporation
                8.4.9.1 Business Description
                8.4.9.2 Luminex Corporation Geographic Operations
                8.4.9.3 Luminex Corporation Financial Information
                8.4.9.4 Luminex Corporation Product Positions/Portfolio
                8.4.9.5 Luminex Corporation Key Developments
        8.4.10 Meridian Bioscience, Inc
                8.4.10.1 Business Description
                8.4.10.2 Meridian Bioscience, Inc Geographic Operations
                8.4.10.3 Meridian Bioscience, Inc Financial Information
                8.4.10.4 Meridian Bioscience, Inc Product Positions/Portfolio
                8.4.10.5 Meridian Bioscience, Inc Key Developments
        8.4.11 uidel Corporation
                8.4.11.1 Business Description
                8.4.11.2 uidel Corporation Geographic Operations
                8.4.11.3 uidel Corporation Financial Information
                8.4.11.4 uidel Corporation Product Positions/Portfolio
                8.4.11.5 uidel Corporation Key Developments
        8.4.12 hermo Fisher Scientific Inc.
                8.4.12.1 Business Description
                8.4.12.2 hermo Fisher Scientific Inc. Geographic Operations
                8.4.12.3 hermo Fisher Scientific Inc. Financial Information
                8.4.12.4 hermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.12.5 hermo Fisher Scientific Inc. Key Developments
        8.4.13 ologic
                8.4.13.1 Business Description
                8.4.13.2 ologic Geographic Operations
                8.4.13.3 ologic Financial Information
                8.4.13.4 ologic Product Positions/Portfolio
                8.4.13.5 ologic Key Developments
        8.4.14 oris Bioconcept'
                8.4.14.1 Business Description
                8.4.14.2 oris Bioconcept' Geographic Operations
                8.4.14.3 oris Bioconcept' Financial Information
                8.4.14.4 oris Bioconcept' Product Positions/Portfolio
                8.4.14.5 oris Bioconcept' Key Developments
        8.4.15 enome Diagnostic
                8.4.15.1 Business Description
                8.4.15.2 enome Diagnostic Geographic Operations
                8.4.15.3 enome Diagnostic Financial Information
                8.4.15.4 enome Diagnostic Product Positions/Portfolio
                8.4.15.5 enome Diagnostic Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global General Influenza Diagnostics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America General Influenza Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America General Influenza Diagnostics Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America General Influenza Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe General Influenza Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe General Influenza Diagnostics Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe General Influenza Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific General Influenza Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific General Influenza Diagnostics Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific General Influenza Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America General Influenza Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America General Influenza Diagnostics Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America General Influenza Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA General Influenza Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA General Influenza Diagnostics Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA General Influenza Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global General Influenza Diagnostics: Market Segmentation 
FIG. 2 Global General Influenza Diagnostics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global General Influenza Diagnostics Market, By Test Type, 2019 (US$ Mn) 
FIG. 5 Global General Influenza Diagnostics Market, By End-User, 2019 (US$ Mn) 
FIG. 6 Global General Influenza Diagnostics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global General Influenza Diagnostics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global General Influenza Diagnostics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key General Influenza Diagnostics Providers, 2019
FIG. 11 Global General Influenza Diagnostics Market Revenue Contribution, By Test Type, 2019 & 2028 (Value %) 
FIG. 12 Global General Influenza Diagnostics Market Revenue Contribution, By End-User, 2019 & 2028 (Value %) 
FIG. 13 Global General Influenza Diagnostics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America General Influenza Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe General Influenza Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific General Influenza Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America General Influenza Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA General Influenza Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the General Influenza Diagnostics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global General Influenza Diagnostics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America General Influenza Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  North America General Influenza Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  North America General Influenza Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Europe General Influenza Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Europe General Influenza Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Europe General Influenza Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific General Influenza Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific General Influenza Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific General Influenza Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Latin America General Influenza Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America General Influenza Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America General Influenza Diagnostics Market Value, By Country, 2018 – 2028
TABLE  MEA General Influenza Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  MEA General Influenza Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  MEA General Influenza Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Endress+Hauser (Analytik Jena AG): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Becton, Dickinson and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  bioMérieux Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation (Cepheid): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GenMark Diagnostics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Luminex Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Meridian Bioscience, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  uidel Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  hermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ologic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  oris Bioconcept': Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  enome Diagnostic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global General Influenza Diagnostics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global General Influenza Diagnostics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global General Influenza Diagnostics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global General Influenza Diagnostics Market, By Geography, 2019 (US$ Mn)
FIG.  Global General Influenza Diagnostics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key General Influenza Diagnostics Providers, 2016
FIG.  Global General Influenza Diagnostics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Traditional Diagnostic Tests Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global General Influenza Diagnostics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Diagnostic Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Research and Academic Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Contract Research Organizations Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CROs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA General Influenza Diagnostics Market Value, 2018 – 2028, (US$ Mn)